Vision Monday VMail Weekend

September 19, 2020|


First-of-Its-Kind Artificial Vision System Moves to Clinical Trials

With millions of people worldwide who are blind or suffering from sight-robbing diseases, and millions more expected to lose their vision over the next few years, a growing number of private companies and research institutes are working to develop bionic eyes, artificial vision systems and advanced visual prostheses. One of the newest projects is being undertaken by Illinois Institute of Technology. Researchers there were recently awarded $2.5 million by the National Institutes of Health (NIH) to fund the first year of a three-year project which involves clinical trials of a first-of-its-kind wireless visual prosthesis system which aims to provide some limited vision to people with profound blindness.
Read More

In Case you Missed It - VMail's Top Stories of the Week

US Eye Network expands in South Carolina, MetLife to acquire Versant Health for $1.7 billion, Omni Group partners with Eye Care Northwest, national ECP revenues and category indexes decline nationwide, and CovalentEvents launches Eyes on 2021 for optometry community all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

US Eye Network Expands in South Carolina

MetLife to Acquire Versant Health for $1.7 Billion

Omni Group Partners With Eye Care Northwest

Jobson Tracker: National ECP Revenues and Category Indexes Decline Nationwide

CovalentEvents Launches Eyes On 2021 for Optometry Community

Insta Pick - Noteworthy Posts From the People We Follow

Editor's Pick

Facebook and EssilorLuxottica to Collaborate on Smart Glasses, Starting With a Ray-Ban Launch in 2021

MENLO PARK, California, and CHARENTON-LE-PONT, France—Facebook, Inc. and EssilorLuxottica  just announced a multiyear collaboration to develop the next generation of smart glasses. The announcement was made by Mark Zuckerberg during Facebook Connect, an annual conference held virtually from California. The partnership will combine “Facebook apps and technologies, Luxottica’s category leadership and iconic brands, and Essilor’s advanced lens technology to help people stay better connected to their friends and family,” according to a joint announcement from Facebook and EssilorLuxottica that was issued on Sept. 16.
Read More


VM's News Quiz

VM's News Quiz for the Week of Sept. 13: Facebook and EssilorLuxottica Team Up, VSP Creates New Position and Glasses May Cut COVID-19 Risk

Did you follow the optical news this week? Take VM’s News Quiz to see how much you know. This week's quiz takes a look at a product collaboration between Facebook and EssilorLuxottica, VSP creates a new executive slot and why wearing glasses may cut your risk of catching the virus. Click here to take the quiz for the week of September 13. VM's News Quiz is published every Saturday as part of VMAIL Weekend.
Click here to take the quiz.

Tweet of the Week

We Share It

Who doesn’t want little animal optometrists on their badge holder? You can customize this adorable accessory on Etsy. #WeShareIt  

Community Voices

Problem Solved: How to Keep Frames Sanitary in the Dispensary

Since the start of the coronavirus pandemic, eyecare professionals have adopted strict hygiene protocols. That puts pressure on their ability to serve the same number of patients they used to see before COVID-19. To address the situation, Zeiss Vision Care US is launching Zeiss UVClean technology, an optometry-specific UV-C disinfecting device designed especially for eyecare professionals and developed in conjunction with Voxelight, LLC. Intended for the dispensary Zeiss UVClean alleviates the high costs that have become the new normal in a COVID-19 environment. Zeiss developed the device with the insight and support of several practices across the U.S. including Carrboro Family Vision in North Carolina.
Read More


Interested in more from VisionMonday and VMail? Click here to subscribe to our other e-newsletters.

VMail Weekend is published by Jobson Medical Information LLC, 395 Hudson Street, New York, NY 10014.

To subscribe to other JMI newsletters or to manage your subscription, click here.